NASDAQ:ITRM
Iterum Therapeutics Plc Stock Company Profile
$1.54
-0.0500 (-3.14%)
At Close: Mar 28, 2024
Information
Fitzwilliam Court, 1st Floor Leeson Close
Dublin 2
353 1 669 4820
www.iterumtx.com
Industry: Biotechnology
Sector: Healthcare
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.